A recently published meta-analysis investigated the overall association of TAM to SCCHN based solely on the markers CD68 and CD163, concluding that increased stromal CD168+ detection of M2 TAMs was correlated with worse OS. This evidence concerns the gene CD68 and head and neck squamous cell carcinoma.